EFTA00304997.pdf

410) Quest Diagnostics Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Chentheonnation EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 64 Gender: M Phone: Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: MR156329E Requisition: 0004002 Collected: Received: Reported: 01/05/2018 01/05/2018 122:36 EST 01/08/2018 123:26 EST Teat Name LIPID PANEL CHOLESTEROL, TOTAL HDL CHOLESTEROL TRIGLYCERIDES LDL-CHOLESTEROL In Range Out Of 207 H 28 L 510 H Range LDL cholesterol not calculated. Triglyceride levels greater than 400 mg/dL invalidate calculated LDL results. Reference range: <100 Desirable range <100 mg/dL for patients with CHD or diabetes and <70 mg/dL for diabetic patients with known heart disease. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al. JAMA. 2013;310(19): 2061-2068 (http://education.QuestDiagnostics.com/faq/FAQ164) CHOL/HDLC RATIO 7.4 H NON HDL CHOLESTEROL 179 H For patients with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.2 Average relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk According to AHA/CDC Guidelines Lower relative cardiovascular risk. Average relative cardiovascular risk. Higher relative cardiovascular risk. Consider retesting in 1 to 2 weeks to exclude a benign transient elevation in the baseline CRP value secondary to infection or inflammation. Persistent elevation, upon retesting, may be associated with infection and inflammation. Client #: 78300020 56W5265 MOSKOWITZ. BRUCE W BRUCE MOSKOWITZ, MD Attn: NATIONWIDE ACCOUNT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401-3418 Reference Range <200 mg/dL >40 mg/dL <150 mg/dL mg/dL (talc) <5.0 (talc) <130 mg/dL (talc) mg/L HOMOCYSTEINE 13.7 H <11.4 Homocysteine is increased by functional deficiency of folate or vitamin B12. Testing for methylmalonic acid differentiates between these deficiencies. Other causes of increased homocysteine include renal failure, folate antagonists such as methotrexate and phenytoin, and exposure to nitrous oxide. Lab MI MI MI MI MI MI TP umol/L MI CLIENT SERVICES: 866.697.8378 SPECIMEN: MR156329E Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGE I OF 5 EFTA00304997 60) Quest Diagnostics' —.• Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 64 Gender: M Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: MR156329E Collected: 01/05/2018 Received: 01/05/2018 / 22:36 EST Reported: 01/08/2018 /23:26 EST Client #: 78300020 MOSKOWITZ, BRUCE W Test Name COMPREHENSIVE METABOLIC PANEL GLUCOSE In Range 90 Out Of Range Reference Range UREA NITROGEN (BUN) 20 CREATININE 1.10 For patients >49 years of age, the reference limit for Creatinine is approximately 13% higher for people identified as African-American. eGFR NON-AFR. AMERICAN eGFR AFRICAN AMERICAN BUN/CREATININE RATIO SODIUM POTASSIUM CHLORIDE CARBON DIOXIDE CALCIUM PROTEIN, TOTAL ALBUMIN GLOBULIN ALBUMIN/GLOBULIN RATIO BILIRUBIN, TOTAL ALKALINE PHOSPHATASE AST ALT HEMOGLOBIN Alc 65-99 mg/dL Fasting reference interval 7-25 mg/dL 0.70-1.25 mg/dL Lab MI 71 82 NOT APPLICABLE 147 H > OR = 60 mL/min/1.73m2 > OR = 60 mL/min/1.73m2 6-22 (talc) 135-146 mmol/L 4.7 3.5-5.3 mmol/L 112 H 98-110 mmol/L 23 20-31 mmol/L 9.8 8.6-10.3 mg/dL 7.3 6.1-8.1 g/dL 4.3 3.6-5.1 g/dL 3.0 1.9-3.7 g/dL (talc) 1.4 1.0-2.5 (talc) 0.8 0.2-1.2 mg/dL 56 40-115 U/L 22 10-35 U/L 26 9-46 U/L 5.5 <5.7 % of total Hgb MI For the purpose of screening for the presence of diabetes: <5.7% Consistent with 5.7-6.4% Consistent with (prediabetes) > or =6.5% Consistent with the absence of diabetes increased risk for diabetes diabetes This assay result is consistent with a decreased risk of diabetes. Currently, no consensus exists regarding use of hemoglobin Alc for diagnosis of diabetes in children. According to American Diabetes Association (ADA) guidelines, hemoglobin Alc <7.0% represents optimal control in non-pregnant diabetic patients. Different metrics may apply to specific patient populations. Standards of Medical Care in Diabetes(ADA). URIC ACID 8.0 Therapeutic target for gout patients: <6.0 mg/dL TSH T4 (THYROXINE), TOTAL FREE T4 INDEX (T7) T3 UPTAKE 3.05 7.8 2.1 27 4.0-8.0 mg/dL 0.40-4.50 mIU/L 4.5-12.0 mcg/dL 1.4-3.8 22-35 % MI MI MI MI CLIENT SERVICES: 866.697.8378 SPECIMEN: MRI56329E Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGE 2 OF 5 EFTA00304998 611) Quest —00 Diagnostics Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 64 Gender: M Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: Collected: Received: Reported: MR156329E 01/05/2018 01/05/2018 /22:36 EST 01/08/2018 /23:26 EST Test Name SED RATE BY MODIFIED WESTERGREN CBC (INCLUDES DIFF/PLT) WHITE BLOOD CELL COUNT RED BLOOD CELL COUNT HEMOGLOBIN HEMATOCRIT MCV MCH MCHC RDW PLATELET COUNT MPV ABSOLUTE NEUTROPHILS ABSOLUTE LYMPHOCYTES ABSOLUTE MONOCYTES ABSOLUTE EOSINOPHILS ABSOLUTE BASOPHILS NEUTROPHILS LYMPHOCYTES MONOCYTES EOSINOPHILS BASOPHILS URINALYSIS, COMPLETE COLOR APPEARANCE SPECIFIC GRAVITY PH GLUCOSE BILIRUBIN KETONES OCCULT BLOOD PROTEIN NITRITE LEUKOCYTE ESTERASE WBC RBC SQUAMOUS EPITHELIAL CELLS BACTERIA HYALINE CAST VITAMIN B12 C-REACTIVE PROTEIN MERCURY, BLOOD In Range 9 Out Of Range Clientheonnation Client #: 78300020 MOSKOWITZ, BRUCE W Reference Range < OR = 20 mm/h 6.2 3.8-10.8 Thousand/uL 5.17 4.20-5.80 Million/uL 14.9 13.2-17.1 g/dL 43.8 38.5-50.0 % 84.7 80.0-100.0 fL 28.8 27.0-33.0 pg 34.0 32.0-36.0 g/dL 13.7 11.0-15.0 % 265 140-400 Thousand/uL 10.3 7.5-12.5 fL 2895 1500-7800 cells/uL 2331 850-3900 cells/uL 515 200-950 cells/uL 391 15-500 cells/uL 68 0-200 cells/uL 46.7 37.6 8.3 6.3 1.1 YELLOW CLEAR 1.023 < OR = 5.0 NEGATIVE NEGATIVE NEGATIVE NEGATIVE NEGATIVE NEGATIVE NEGATIVE NONE SEEN 0-2 NONE SEEN NONE SEEN NONE SEEN 471 1.4 <5 This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes. TESTOSTERONE, TOTAL MALES (ADULT), IA TESTOSTERONE, TOTAL, MALES (ADULT), IA 150 L In hypogonadal males, Testosterone, Total, LC/MS/MS, is the recommended assay due to the diminished accuracy of immunoassay at levels below 250 ng/dL. YELLOW CLEAR 1.001-1.035 5.0-8.0 NEGATIVE NEGATIVE NEGATIVE NEGATIVE NEGATIVE NEGATIVE NEGATIVE < OR = 5 /HPF < OR = 2 /HPF < OR = 5 /HPF NONE SEEN /HPF NONE SEEN /LPF 200-1100 pg/mL <8.0 mg/L <OR=10 mcg/L 250-827 ng/dL Lab MI MI MI MI MI AT MI CLIENT SERVICES: 866.697.8378 SPECIMEN: MR156329E Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGE30F5 EFTA00304999 rajQuest Diagnostics' —.0 Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 64 Gender: M Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: MR156329E Collected: 01/05/2018 Received: 01/05/2018 / 22:36 EST Reported: 01/08/2018 / 23:26 EST Client #: 78300020 MOSKOWITZ, BRUCE W Test Name In Range Out Of Range This test code (15983) must be collected in a red-top tube with no gel. PSA, TOTAL 0.5 The total PSA value from this assay system is standardized against the WHO standard. The test result will be approximately 20% lower when compared to the equimolar-standardized total PSA (Beckman Coulter). Comparison of serial PSA results should be interpreted with this fact in mind. This test was performed using the Siemens chemiluminescent method. Values obtained from different assay methods cannot be used interchangeably. PSA levels, regardless of value, should not be interpreted as absolute evidence of the presence or absence of disease. Reference Range < OR = 4.0 ng/mL Lab MI CLIENTSERIIICES:866.6971378 SPECIMEN: MR156329E PAGE 4 OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00305000 Quest Diagnostics Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 64 Gender: M Patient ID: 19530120NUE Health ID: 8573003290851249 Specimen: MR156329E Collected: 01/05/2018 Received: 01/05/2018 / 22:36 EST Reported: 01/08/2018 / 23:26 EST Client #: 78300020 MOSKOWITZ. BRUCE W Endocrinology Test Name Result Reference Range Lab VITAMIN D,25-OH,TOTAL,IA Vitamin D Status 35 30-100 ng/mL MI Deficiency: Insufficiency: Optimal: For 25-OH Vitamin D testing on patients on D2-supplementation and patients for whom quantitation of D2 and D3 fractions is required, the OuestAssureD(TM) 25-OH VIT D, (D2,D3), LC/MS/MS is recommended: order code 92888 (patients >2yrs). For more information on this test, go to: http:fieducation.questdiagnostics.com/faq/FAC1163 (This link is being provided for informational/ educational purposes only.) 25-OH Vitamin D: <20 ng/mL 20 - 29 ng/mL > or = 30 ng/mL Physician Comments: PERFORMING SITE: AT QUEST DIAGNOSTICS.A1LANTA. 1777 MONTREAL CIRCLE.11JCICER. GA 30084-6S02 laboratory Dutch:. ANDREW N YOUNG.MD.PIID.CLIA: 1100255931 MI QUEST DIAGNOSTICS.MIAMI 10200 COMMERCE PARKWAY. MIRAMAR. Fl. 33015-3938 Laboratory Director GLEN L 11OR11N MD PHD. CLIA: 10/1027731/ TP QUEST DIAGNOSTICS.TAMPA. 1223 E FOWLER AVE TAMPA. It 33617.2026 Laboratory Director. GLEN L HORTIN.MDAID. CL1A: 10110291120 CLIENT SERVICES: 866.697.8378 SPECIMEN: MR156329E PAGE 5 OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00305001